Added Value of a Small Camera (Iriscope) in the Endoscopic Diagnosis of Peripheral Lung Nodules and Masses

NCT ID: NCT05445635

Last Updated: 2024-08-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

91 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-06-02

Study Completion Date

2024-08-26

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Since the beginning of lung screening program in the different countries around the world by chest CT scan, numerous lung nodules and masses of unknown etiology are diagnosed.

Usually, the pathological diagnosis is obtained by bronchoscopy. However, peripheral bronchi cannot be seen after the fifth bronchial division as the diameter of the broncoscope is greated than the diameter of the bronchi. Therefore, the Iriscope was developed. It consists in a thin catheter with a mini-camera at its distal extremity.

The aime of this study is to evaluate the diagnostic yield of bronchoscopy guided by Iriscope in the setting of peripheral lung nodules and masses supect of malignancy, to compare the Iriscope to endobronchial radial ultrasonography (which is a validated technique to guide bronchoscopy in the setting of peripheral lung nodules and masses) and to evaluate the added value on the diagnostic yield by combining these 2 techniques.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pulmonary Nodule, Solitary

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Iriscope

Group Type EXPERIMENTAL

Iriscope

Intervention Type DEVICE

The use of Iriscope to improve the diagnostic yield of bronchoscopy in the setting of peripheral lung nodules

EBUS

Group Type ACTIVE_COMPARATOR

Iriscope

Intervention Type DEVICE

The use of Iriscope to improve the diagnostic yield of bronchoscopy in the setting of peripheral lung nodules

Combined Iriscope + EBUS

Group Type EXPERIMENTAL

Iriscope

Intervention Type DEVICE

The use of Iriscope to improve the diagnostic yield of bronchoscopy in the setting of peripheral lung nodules

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Iriscope

The use of Iriscope to improve the diagnostic yield of bronchoscopy in the setting of peripheral lung nodules

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Lung nodules or masses suspect of malignancy with a diameter between 2 and 5 centimeters

Exclusion Criteria

* Any contraindication to general anesthesia
* Coagulopathy
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Erasme University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Olivier Taton

Doctor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Olivier Taton, Resident

Role: PRINCIPAL_INVESTIGATOR

Hôpital Erasme, Université Libre de Brussels, Brussels, Belgium

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Erasme Hospital

Brussels, , Belgium

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P2021/770

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Sd-RAB for the Diagnosis of PPLs
NCT06719687 NOT_YET_RECRUITING NA
Image - Navigated Resection of Lung Nodules
NCT04702165 COMPLETED PHASE1/PHASE2